GUAIFENESIN AND PSEUDOEPHEDRINE HCL
Generic: GUAIFENESIN AND PSEUDOEPHEDRINE HCL
Amerisource BergenManufacturer
ORALRoute
GUAIFENESINActive Substance
2020-03-25Original Approval
GUAIFENESIN AND PSEUDOEPHEDRINE HCL is FDA application ANDA213203, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
ALANINE AMINOTRANSFERASE INCREASED
1 reports
2
ARTHRITIS
1 reports
3
ASPARTATE AMINOTRANSFERASE INCREASED
1 reports
4
BLOOD ALKALINE PHOSPHATASE INCREASED
1 reports
5
BLOOD CHLORIDE DECREASED
1 reports
6
BLOOD CHOLESTEROL INCREASED
1 reports
7
BLOOD SODIUM DECREASED
1 reports
8
BRONCHITIS
1 reports
9
CHOLELITHIASIS
1 reports
10
DEEP VEIN THROMBOSIS
1 reports